Table: Kidswell Bio -Q1 group results
Aug 14 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 482 mln
Operating loss 158 mln
Recurring loss 176 mln
Net loss 176 mln
EPS loss 4.49 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Kidswell Bio Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T